A new molecule disrupts tuberculosis by cutting off cholesterol
Increasing cAMP production blocks tuberculosis’ cholesterol metabolism, impairing its pathogenesis in mice.
Daily News
CRISPR-based muscular dystrophy therapy
CRISPR-based muscular dystrophy therapy
An engineer turned biology researcher co-founded a bio-pharma start-up with the goal of using CRISPR to reverse the mutation causing the degenerative muscle disorder Duchenne muscular dystrophy.
Psilocybin may effectively treat addiction
Psilocybin may effectively treat addiction
Psilocybin research was "outlawed" in the 70s, but it's back now. It may offer a powerful new tool for treating addictions to substances such as alcohol, cigarettes, and opioids.
Drug safety during pregnancy
Drug safety during pregnancy
Pregnant people with mental health disorders such as depression or bipolar disorder often face an impossible decision: risk their health or their future child's health by discontinuing or continuing their medication.
Special report: Live and let die
Special report: Live and let die
Researchers redefine cell death in disease and drug discovery.
A neurosteroid hope for postpartum depression
A neurosteroid hope for postpartum depression
A pioneer in reproductive psychiatry, Samantha Meltzer-Brody investigates new therapeutics for depression during and after pregnancy.
Decoding cell behavior and disease with AI and single-cell transcriptomics
Decoding cell behavior and disease with AI and single-cell transcriptomics
Machine learning paired with single-cell analysis helps scientists identify pathways that cause disease and potential therapeutics.
